| Trial name or title |
Cycle Control and Safety of E2‐DRSP |
| Methods |
Randomized, double‐blind, multicenter |
| Participants |
600 healthy women, 18 to 35 years |
| Interventions |
6 different regimens of drospirenone and ethinyl estradiol (including monophasic and triphasic) over 7 cycles (details not provided) |
| Outcomes |
include bleeding patterns and cycle control |
| Starting date |
March 2008 |
| Contact information |
Bayer Study Director (no more information provided) |
| Notes |
Completed June 2009. No report found; searched PubMed and http://www.clinicalstudyresults.org/ |
